Meeder Asset Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,793
| Closed | -$123K | – | 2540 |
|
|
2019
Q3 | $123K | Sell |
1,793
-3,937
| -69% | -$270K | 0.01% | 743 |
|
|
2019
Q2 | $333K | Buy |
5,730
+2,839
| +98% | +$165K | 0.02% | 473 |
|
|
2019
Q1 | $203K | Hold |
2,891
| – | – | 0.02% | 548 |
|
|
2018
Q4 | $186K | Sell |
2,891
-1,723
| -37% | -$111K | 0.02% | 515 |
|
|
2018
Q3 | $323K | Sell |
4,614
-3,951
| -46% | -$277K | 0.02% | 424 |
|
|
2018
Q2 | $432K | Buy |
8,565
+4,765
| +125% | +$240K | 0.04% | 379 |
|
|
2018
Q1 | $118K | Buy |
3,800
+840
| +28% | +$26.1K | 0.01% | 524 |
|
|
2017
Q4 | $101K | Buy |
2,960
+1,619
| +121% | +$55.2K | 0.01% | 563 |
|
|
2017
Q3 | $43K | Buy |
1,341
+420
| +46% | +$13.5K | ﹤0.01% | 714 |
|
|
2017
Q2 | $30K | Buy |
921
+604
| +191% | +$19.7K | ﹤0.01% | 755 |
|
|
2017
Q1 | $10K | Buy |
+317
| New | +$10K | ﹤0.01% | 868 |
|